Presidio Medical vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Presidio Medical develops an ultra-low frequency (ULF) spinal cord stimulation platform for nociceptive lower back pain; raised $102M total including $72M Series C from Deerfield; 95% responder rate in trials.
About
Presidio Medical is a clinical-stage medical technology company developing a next-generation neuromodulation platform for treating chronic nociceptive lower back pain. Founded in 2017 and headquartered in South San Francisco, California, the company''s Ultra Low Frequency (ULF™) Neuromodulation System delivers precisely calibrated, ultra-low frequency electrical pulses through spinal cord stimulation (SCS) electrodes to inhibit neuronal pain responses localized to the lower back — without relying on paresthesia (the tingling sensation associated with older SCS devices).
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.